38 min listen
Episode 10: Parkinson’s Disease - The Future of Cell and Gene Therapies
Episode 10: Parkinson’s Disease - The Future of Cell and Gene Therapies
ratings:
Length:
27 minutes
Released:
Nov 21, 2023
Format:
Podcast episode
Description
Over 10 million people worldwide are suffering from Parkinson’s Disease — the most common neurodegenerative movement disorder in the world. Join us as our expert panel discusses why Parkinson’s remains so hard to treat, and how cell and gene therapies could potentially offer a paradigm shift from current treatment options.
In this episode of Headlines of the Future, host Piyal Bhoora is joined by Dr. Krystof Bankiewicz, Scientific Chair, Parkinson’s and MSA at AskBio; Dr. Ahmed Enayetallah, Head of Development at Bluerock Therapeutics; and Dr. Patrick Bussfeld, Head of Medical Affairs, Cell & Gene Therapies and Ophthalmology at Bayer.
In this episode of Headlines of the Future, host Piyal Bhoora is joined by Dr. Krystof Bankiewicz, Scientific Chair, Parkinson’s and MSA at AskBio; Dr. Ahmed Enayetallah, Head of Development at Bluerock Therapeutics; and Dr. Patrick Bussfeld, Head of Medical Affairs, Cell & Gene Therapies and Ophthalmology at Bayer.
Released:
Nov 21, 2023
Format:
Podcast episode
Titles in the series (11)
Episode 1: The Bio Revolution: The life sciences and digitalization are becoming increasingly intertwined, enabling a Bio Revolution with disruptive technologies that could have a big impact on improving our daily lives. In health, this could mean moving from treating to curing and pr... by Headlines of the Future